Download Citation
Article Source:
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
Trotta MC,
Maisto R,
Guida F,
Boccella S,
Luongo L,
et al.
(2019)
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.
PLOS ONE 14(1): e0211005.
https://doi.org/10.1371/journal.pone.0211005